Daiwa Securities Group
BOLD

Daiwa Securities Group’s Audentes Therapeutics, Inc BOLD Stock Holding History

Daiwa Securities Group’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-290
Closed -$17K – 1252
2019
Q4 		$17K Hold
290
– – ﹤0.01% 1030
2019
Q3 		$8K Buy
290
+19
+7% +$648 ﹤0.01% 1050
2019
Q2 		$10K Hold
271
– – ﹤0.01% 1058
2019
Q1 		$11K Buy
271
+106
+64% +$3.04K ﹤0.01% 1033
2018
Q4 		$4K Hold
165
– – ﹤0.01% 1082
2018
Q3 		$7K Hold
165
– – ﹤0.01% 1070
2018
Q2 		$6K Hold
165
– – ﹤0.01% 1091
2018
Q1 		$5K Buy
+165
New +$5.59K ﹤0.01% 1082

Daiwa Securities Group's BOLD Position: Q1 2020 in Review

Daiwa Securities Group sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 290 shares — an estimated $17K sold.

Daiwa Securities Group first reported a position in BOLD in Q1 2018 and held it in 8 quarters. The position peaked at $17K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Daiwa Securities Group reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Daiwa Securities Group sold 290 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $17K.
  • Daiwa Securities Group first reported a position in Audentes Therapeutics, Inc in Q1 2018 and held it in 8 quarters.
  • Daiwa Securities Group's Audentes Therapeutics, Inc position peaked at $17K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Daiwa Securities Group's 13F filing for Q1 2020, filed 14 May 2020.